Leukotriene receptor antagonists and related compounds

Canadian Respiratory Journal

Volumn 6, Issue 2, 1999, Pages 189-193

  Wenzel, Sally E ^a  

^a NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

Author keywords

5 Lipoxygenase inhibitors; Inflammation; Inhaled corticosteroids; Leukotriene receptor antagonists

Indexed keywords

ACETYLSALICYLIC ACID; ALLERGEN; ARACHIDONATE 5 LIPOXYGENASE; BECLOMETASONE; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CELL RECEPTOR; CORTICOSTEROID; CYSTEINE; LEUKOTRIENE; LEUKOTRIENE B4; LEUKOTRIENE RECEPTOR BLOCKING AGENT; LIPOXYGENASE INHIBITOR; MONTELUKAST; PRANLUKAST; ZAFIRLUKAST; ZILEUTON;

ASTHMA; CHURG STRAUSS SYNDROME; DISEASE SEVERITY; DRUG SAFETY; EXERCISE INDUCED ASTHMA; FORCED EXPIRATORY VOLUME; HUMAN; INHALATIONAL DRUG ADMINISTRATION; ORAL DRUG ADMINISTRATION; PRACTICE GUIDELINE; PRIORITY JOURNAL; RESPIRATORY TRACT INFLAMMATION; REVIEW; SYMPTOMATOLOGY; TACHYPHYLAXIS;

EID: 0032969569     PISSN: 11982241     EISSN: None     Source Type: Journal    
DOI: 10.1155/1999/676798     Document Type: Review

References (2)

1. Henderson WR Jr. The role of leukotrienes in inflammation. Ann Intern Med 1994;121:684-97.
2. Lewis RA, Austen F, Soberman RJ. Leukotrienes and other products of the 5-lipoxygenase pathway. N Engl J Med 1990;323:645-55.